Wegovy without the needle sparks Novo surge

Novo Nordisk (NVO) rises as FDA approves Wegovy pill for obesity. (00:24) Mercedes (MBGAF) to pay $150M settlement over diesel scandal. (01:09) ByteDance (BDNCE) plans $23B capex for 2026 with focus on AI infrastructure - FT. (01:57)Episode transcripts seekingalpha.com/wsb.Show links: Biggest stock movers Tuesday: ZIM, NVO, and moreThe ‘Santa Claus rally’ is here, now prepare for the ‘January effect’ – analystCiti 2026 semis outlook: MCHP top pick, AVGO, ADI, MU, NXPI, TXN buy-ratedRyanair Holdings shares surge 55%, leading European airline stocks in 2025Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.